GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Biostar Pharmaceuticals Inc (OTCPK:BSPM) » Definitions » Shiller PE Ratio

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Shiller PE Ratio : 0.00 (As of Apr. 25, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Biostar Pharmaceuticals Shiller PE Ratio?

As of today (2024-04-25), Biostar Pharmaceuticals's current share price is $0.0001. Biostar Pharmaceuticals's E10 for the quarter that ended in Sep. 2017 was $1.09. Biostar Pharmaceuticals's Shiller PE Ratio for today is 0.00.

The historical rank and industry rank for Biostar Pharmaceuticals's Shiller PE Ratio or its related term are showing as below:

BSPM's Shiller PE Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 24.47
* Ranked among companies with meaningful Shiller PE Ratio only.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Biostar Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2017 was $-0.050. Add all the adjusted EPS for the past 10 years together and divide 10 will get our E10, which is $1.09 for the trailing ten years ended in Sep. 2017.

Shiller PE for Stocks: The True Measure of Stock Valuation


Biostar Pharmaceuticals Shiller PE Ratio Historical Data

The historical data trend for Biostar Pharmaceuticals's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biostar Pharmaceuticals Shiller PE Ratio Chart

Biostar Pharmaceuticals Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Biostar Pharmaceuticals Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - 1.20 1.22

Competitive Comparison of Biostar Pharmaceuticals's Shiller PE Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Biostar Pharmaceuticals's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biostar Pharmaceuticals's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Biostar Pharmaceuticals's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Biostar Pharmaceuticals's Shiller PE Ratio falls into.



Biostar Pharmaceuticals Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Biostar Pharmaceuticals's Shiller PE Ratio for today is calculated as

Shiller PE Ratio=Share Price/ E10
=0.0001/1.09
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biostar Pharmaceuticals's E10 for the quarter that ended in Sep. 2017 is calculated as:

For example, Biostar Pharmaceuticals's adjusted earnings per share data for the three months ended in Sep. 2017 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2017 (Change)*Current CPI (Sep. 2017)
=-0.05/104.1000*104.1000
=-0.050

Current CPI (Sep. 2017) = 104.1000.

Biostar Pharmaceuticals Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
200712 0.840 82.911 1.055
200803 1.680 85.485 2.046
200806 1.680 85.058 2.056
200809 0.420 85.057 0.514
200812 0.840 83.956 1.042
200903 1.680 84.457 2.071
200906 3.360 83.615 4.183
200909 2.730 84.369 3.368
200912 -1.050 85.386 -1.280
201003 1.680 86.316 2.026
201006 4.200 85.886 5.091
201009 2.730 87.267 3.257
201012 4.620 89.289 5.386
201103 2.098 91.154 2.396
201106 3.150 91.612 3.579
201109 3.290 92.711 3.694
201112 0.630 92.885 0.706
201203 1.610 94.367 1.776
201206 -7.070 93.495 -7.872
201209 -4.410 94.482 -4.859
201212 -4.760 95.237 -5.203
201303 0.420 96.372 0.454
201306 -0.420 95.984 -0.456
201309 0.210 97.332 0.225
201312 0.350 97.624 0.373
201403 0.140 98.600 0.148
201406 0.770 98.200 0.816
201409 0.140 98.900 0.147
201412 1.250 99.000 1.314
201503 -0.070 99.900 -0.073
201506 -0.220 99.500 -0.230
201509 -0.570 100.500 -0.590
201512 -10.540 100.600 -10.907
201603 -0.280 102.200 -0.285
201606 -3.120 101.400 -3.203
201609 -0.710 102.400 -0.722
201612 1.610 102.600 1.634
201703 -0.380 103.200 -0.383
201706 -0.500 103.100 -0.505
201709 -0.050 104.100 -0.050

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Biostar Pharmaceuticals  (OTCPK:BSPM) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Biostar Pharmaceuticals Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Biostar Pharmaceuticals's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Biostar Pharmaceuticals (Biostar Pharmaceuticals) Business Description

Traded in Other Exchanges
N/A
Address
No. 588 Shiji Xi Avenue, Shaanxi Province, Xianyang, CHN, 712046
Biostar Pharmaceuticals Inc through its subsidiaries involves in the development, manufacturing, and marketing of pharmaceutical products for a variety of diseases and conditions in the People's Republic of China where it generates most of its revenues. The company's products include Xin Ao Xing Oleanolic Acid Capsule, an over-the-counter (OTC) medicine for chronic hepatitis B. The current product line of the company also includes several other OTC products and approximately 15 prescription-based pharmaceuticals. Its products are derived from medicinal herbs that are either grown at its own facility or purchased from the suppliers.

Biostar Pharmaceuticals (Biostar Pharmaceuticals) Headlines